Dr. Shalini Shah’s research interest focuses on the study of pediatric pain medicine, specifically in pediatric migraine pathology and innovative treatment outcomes. Dr. Shah was awarded the American Society of Regional Anesthesia and Pain Medicine (ASRA) Chronic Pain Research Grant for the study of the "Effectiveness of Onabotulinumtoxin A in Pediatric Patients Experiencing Migraines: A Randomized Double-Blinded Placebo Crossover Study in the Pediatric Pain Population”. This study is the first prospective randomized controlled trial of its kind for the indication of pediatric chronic migraine. The UCI Health Division of Pain Medicine is currently leading the initiative in the identification of novel applications of existing therapeutics for pediatric migraines and is the national referral center for pediatric headache pathology and on-going clinical trials.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)